by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersProRx LLC

All Warning Letters

ProRx LLC

Warning LetterOpen

619 Jeffers Cir Exton , PA 19341-2540 United StatesIssued Apr 7, 2026Center for Drug Evaluation and Research (CDER)

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations8

Issue DateApr 7, 2026

Product TypeDrugs

StatusOpen

Letter Details

Firm: ProRx LLC
Location: 619 Jeffers Cir Exton , PA 19341-2540 United States
FEI Number: N/A
Country: United States
Issue Date: April 07, 2026
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

Compounding Pharmacy/Adulterated Drug Products

ProRx LLC FDA Warning Letter, April 7, 2026